Curtiss-Wright price target raised by $25 at Truist, here’s why

Truist raised the firm’s price target on Curtiss-Wright to $250 from $225 and keeps a Buy rating on the shares. After hosting investor meetings with Curtiss-Wright management earlier this week, Truist believes the company’s multiple opportunities within commercial nuclear have the power to drive transformative growth longer-term, the analyst tells investors in a research note. In the near-term, Truist expects that strong execution across the company’s portfolio will support continued organic growth and margin expansion, and believes increased M&A activity in 2024 to be a potential upside catalyst.